CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 122 enrolled
Drug / intervention
NMES device with EMG-triggered and Cyclic capabilitiesdevice
Likely dose
NeuroMove NM900 stimulator: two 40-minute sessions per day, 5 days per week for 8 weeks with surface electrodes over affected EDC and ECRAI-extracted
Key inclusion· 11
  • ✓Age 21–89 years
  • ✓Acute or chronic stroke with complete resolution of any prior stroke symptoms
  • ✓Within 6 months of stroke onset
  • ✓Medically stable
Key exclusion· 9
  • ✕History of ventricular arrhythmias or hemodynamically unstable atrial arrhythmias (fast AF, VT, SVT)
  • ✕History of other upper motor neuron lesion
  • ✕Absent sensation of the affected limb
  • ✕Pregnancy

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00142792
NCT00142792N/ACompleted
CompareCT.gov

Electrical Stimulation for Upper Limb Recovery in Stroke

MetroHealth Medical Center·interventional·Posted Sep 2, 2005·Updated Mar 29, 2018

In Brief

A clinical study evaluating NMES device with EMG-triggered and Cyclic capabilities for Stroke, Acute and 2 related conditions. Completed, enrolled 122 participants across 3 sites.

Detailed Summary

Stroke is the leading cause of activity limitation among older adults in the United States. NeuroMuscular Electrical Stimulation (NMES) can assist stroke survivors in regaining motor ability and decreasing activity limitation caused by stroke. This study will research the effects of two types of NMES on reducing motor impairment and activity limitation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Acute, Stroke, Hemiparesis
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Case Western Reserve University

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 2, 2005
Enrollment StartDec 1, 2005
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 20.8 years ago

Interventions

NMES device with EMG-triggered and Cyclic capabilitiesdevice

All groups will use the NeuroMove NM900 stimulator. Subjects will use the stimulator as described for their group (treatment arm) for two 40-minute sessions per day, 5 days per week for 8 weeks. Surface electrodes for all three groups will be placed over the affected EDC and ECR (finger and wrist extensor) muscles.